These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23979375)

  • 1. Beta-1 blockade in sepsis: what to expect?
    Enkhbaatar P
    Crit Care Med; 2013 Sep; 41(9):2237. PubMed ID: 23979375
    [No Abstract]   [Full Text] [Related]  

  • 2. Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study.
    Morelli A; Donati A; Ertmer C; Rehberg S; Kampmeier T; Orecchioni A; D'Egidio A; Cecchini V; Landoni G; Pietropaoli P; Westphal M; Venditti M; Mebazaa A; Singer M
    Crit Care Med; 2013 Sep; 41(9):2162-8. PubMed ID: 23873274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action and Reaction: The Role of Catecholamine Agonists and Antagonists in Septic Shock.
    Freebairn R
    Crit Care Med; 2015 Sep; 43(9):2039-40. PubMed ID: 26274717
    [No Abstract]   [Full Text] [Related]  

  • 4. Is there a role for β-blockade in septic shock?
    Pinsky MR
    JAMA; 2013 Oct; 310(16):1677-8. PubMed ID: 24108438
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock.
    Wei C; Louis H; Schmitt M; Albuisson E; Orlowski S; Levy B; Kimmoun A
    Crit Care; 2016 Dec; 20(1):407. PubMed ID: 27998289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β1-Adrenergic Inhibition Improves Cardiac and Vascular Function in Experimental Septic Shock.
    Kimmoun A; Louis H; Al Kattani N; Delemazure J; Dessales N; Wei C; Marie PY; Issa K; Levy B
    Crit Care Med; 2015 Sep; 43(9):e332-40. PubMed ID: 25962080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-acting β-blocker administration in patients with septic shock.
    Lin GM
    JAMA; 2014 Feb; 311(7):737. PubMed ID: 24549559
    [No Abstract]   [Full Text] [Related]  

  • 8. Short-acting β-blocker administration in patients with septic shock.
    Bouglé A; Mira JP
    JAMA; 2014 Feb; 311(7):736-7. PubMed ID: 24549558
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-acting β-blocker administration in patients with septic shock.
    Sanfilippo F; Santonocito C; Maybauer MO
    JAMA; 2014 Feb; 311(7):736. PubMed ID: 24549557
    [No Abstract]   [Full Text] [Related]  

  • 10. Short-acting β-blocker administration in patients with septic shock.
    Cortés DO; Taccone FS; Vincent JL
    JAMA; 2014 Feb; 311(7):735-6. PubMed ID: 24549556
    [No Abstract]   [Full Text] [Related]  

  • 11. Short-acting β-blocker administration in patients with septic shock--reply.
    Morelli A; Ertmer C; Singer M
    JAMA; 2014 Feb; 311(7):737-8. PubMed ID: 24549560
    [No Abstract]   [Full Text] [Related]  

  • 12. Should β-blockers be used in septic shock?
    Lira A; Pinsky MR
    Crit Care; 2014 May; 18(3):304. PubMed ID: 25033414
    [No Abstract]   [Full Text] [Related]  

  • 13. Esmolol for tight heart rate control in patients with STEMI: Design and rationale of the beta-blocker in acute myocardial infarction (BEAT-AMI) trial.
    Er F; Erdmann E; Nia AM; Dahlem KM; Biesenbach E; Herrfurth T; Taghiyev Z; Le MT; Hellmich M; Kuhr K; Caglayan E; Gassanov N
    Int J Cardiol; 2015; 190():351-2. PubMed ID: 25939126
    [No Abstract]   [Full Text] [Related]  

  • 14. Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study.
    Morelli A; Singer M; Ranieri VM; D'Egidio A; Mascia L; Orecchioni A; Piscioneri F; Guarracino F; Greco E; Peruzzi M; Biondi-Zoccai G; Frati G; Romano SM
    Intensive Care Med; 2016 Oct; 42(10):1528-1534. PubMed ID: 27101380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial blood pressure and heart rate regulation in shock state.
    DellaVolpe JD; Moore JE; Pinsky MR
    Curr Opin Crit Care; 2015 Oct; 21(5):376-80. PubMed ID: 26263297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diltiazem versus esmolol for acute rate control in the emergency department.
    Harvey S; Wilson K; Brad Hall A
    Am J Emerg Med; 2017 Nov; 35(11):1760-1762. PubMed ID: 28465013
    [No Abstract]   [Full Text] [Related]  

  • 17. To beta block or not to beta block; that is the question.
    Ince C
    Crit Care; 2015 Sep; 19(1):339. PubMed ID: 26400614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut and sublingual microvascular effect of esmolol during septic shock in a porcine model.
    Jacquet-Lagrèze M; Allaouchiche B; Restagno D; Paquet C; Ayoub JY; Etienne J; Vandenesch F; Dauwalder O; Bonnet JM; Junot S
    Crit Care; 2015 Jun; 19(1):241. PubMed ID: 26041462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misdirected Sympathy: The Role of Sympatholysis in Sepsis and Septic Shock.
    Ferreira JA; Bissell BD
    J Intensive Care Med; 2018 Feb; 33(2):74-86. PubMed ID: 28142307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions.
    Nasrollahi-Shirazi S; Sucic S; Yang Q; Freissmuth M; Nanoff C
    J Pharmacol Exp Ther; 2016 Oct; 359(1):73-81. PubMed ID: 27451411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.